Recent research has uncovered troubling evidence that fetuses may be exposed to significantly higher concentrations of per- and polyfluoroalkyl substances (PFAS)—commonly referred to as “forever chemicals”—through umbilical cord blood than previously understood. The study, conducted by Mount Sinai researchers, analysed 120 cord blood samples and identified 42 distinct PFAS compounds, raising serious concerns about the implications for infant health.
A Broadening Scope of Research
Traditionally, tests for PFAS in umbilical cord blood focused on a limited number of well-known compounds, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, the recent study employed a more comprehensive “non-targeted analysis,” which revealed a staggering variety of PFAS compounds. The total quantity of PFAS detected was considerably higher than earlier estimates, indicating that newborns could be facing exposure to numerous toxic substances during a critical development phase.
Shelley Liu, an associate professor at the Icahn School of Medicine and co-author of the study, emphasised the significance of these findings. “It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed,” she stated. The implications of this exposure are profound, given the known health risks associated with PFAS, which include cancer, birth defects, and adverse effects on immune function.
The Health Risks of PFAS
PFAS are a vast group of over 15,000 synthetic chemicals, widely used in products designed to be water-, stain-, and grease-resistant. Dubbed “forever chemicals” due to their persistence in the environment, they are now linked to a multitude of health issues. Studies have shown that elevated PFAS levels in pregnant women correlate with increased rates of infant mortality, as well as potential long-term consequences such as low birth weight and obesity.
A thorough review of existing research has shown PFAS presence in approximately 30,000 umbilical cord blood samples, with alarming associations to neurological problems and cardiovascular diseases later in life. The legacy compounds, such as PFOA and PFOS, were predominant until recent regulatory changes, which have seen them being phased out. However, newer generations of PFAS, which manufacturers claim are less toxic, still pose significant risks, as they may degrade into even more harmful substances within the body or environment.
Regulatory Oversight Lagging
Despite the escalating concerns surrounding PFAS, regulatory bodies have struggled to keep pace with the evolving landscape of these chemicals. For instance, the US Environmental Protection Agency (EPA) primarily tests water samples for 30-40 PFAS compounds, leaving many others undetected. This discrepancy was highlighted in a 2022 analysis, which pointed out that regulators often underestimate PFAS concentrations in water supplies.
The Mount Sinai study’s comprehensive methodology highlights the inadequacy of current testing standards. While the EPA has recently certified a blood test for 53 compounds, the Mount Sinai research identified 31 additional PFAS that remain unmonitored. Liu expressed concern that the broader range of compounds could lead to an underappreciation of the health risks posed to infants.
Future Implications for Health Research
Although the Mount Sinai study did not directly correlate the presence of PFAS with specific health outcomes, Liu acknowledged that elevated levels of these chemicals in blood are generally associated with increased health risks. The blood samples analysed were part of the federal government’s Home Study, which is designed to track individuals’ PFAS exposure and related health effects over time. Researchers plan to delve deeper into the potential health implications of their findings.
David Andrews, acting chief science officer at the Environmental Working Group, underscored the urgency of these results, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The findings of this study are a clarion call to action, highlighting the critical need for updated regulations and more rigorous testing protocols to safeguard maternal and infant health. As evidence mounts regarding the widespread presence of PFAS and their associated risks, it becomes increasingly vital for policymakers to take decisive steps to limit exposure and protect vulnerable populations. The health of future generations may well hinge on our response to this pressing environmental challenge.
